A Study of LY3541860 in Adult Participants With Relapsing Multiple Sclerosis
Clinical trial NCT06220669 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06220669
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-19
- Primary completion
- 2025-10-18
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.